Details of the Drug Formulations

General Information of Drug (ID: DMHOAUG)

• Drug Name: Rimegepant Drug Info
• Synonyms: BMS-927711; 1289023-67-1; UNII-997WVV895X; BMS 927711; CHEMBL2178422; 997WVV895X; (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate; Rimegepant [USAN:INN]; Rimegepant (USAN/INN); SCHEMBL1670580; DTXSID70156003; C28H28F2N6O3; EX-A1922; 3504AH; ZINC68267814; BDBM50400098; AKOS030526382; DB12457; CS-1027; NCGC00378677-01; HY-15498; KB-145921; W-5991

Indication

Disease Entry	ICD 11	Status	REF
Migraine	8A80	Approved	[1]

• Cross-matching ID:
  PubChem CID: 51049968
  CAS Number: 1289023-67-1
  TTD ID: D0V9VG
  VARIDT ID: DR00758
  ACDINA ID: D01393

Full List of Drug Formulations Containing This Drug

Rimegepant eq 75mg base Orally Disintegrating tablet

Company	Formulation ID	FDA Description
Biohaven Pharm	F23275	Benzyl Alcohol; Eucalyptol; Gelatin; Limonene; Mannitol; Menthol; Menthone; Menthyl Acetate; Sucralose; Vanillin

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020